Initial Quality of Life and Toxicity Analysis of a Randomized Phase 3 Study of Moderately Hypofractionated Radiation Therapy With or Without Androgen Suppression for Intermediate-Risk Adenocarcinoma of the Prostate: PCG GU003

PURPOSE: Our objective was to report the quality of life (QoL) analysis and toxicity in patients with intermediate-risk prostate cancer treated with or without androgen deprivation therapy (ADT) in Proton Collaborative Group (PCG) GU003. METHODS AND MATERIALS: Between 2012 and 2019, patients with in...

Descripción completa

Detalles Bibliográficos
Autores principales: Laughlin, Brady S., Thorpe, Cameron S., DeWees, Todd A., Voss, Molly M., Chang, John H., Hartsell, William F., Sinesi, Christopher C., Rwigema, Jean-Claude M., Keole, Sameer R., Gondi, Vinai, Vargas, Carlos E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Scientific Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9991536/
https://www.ncbi.nlm.nih.gov/pubmed/36896215
http://dx.doi.org/10.1016/j.adro.2022.101142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9991536/
https://www.ncbi.nlm.nih.gov/pubmed/36896215
http://dx.doi.org/10.1016/j.adro.2022.101142

Ejemplares similares